Lexaria Bioscience Corp

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$3.43

+0.19 (+5.71%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +671.7% upside

Low Target $20.55

Average Target $26.43

High Target $40.48

Current Price $3.43

Current
$3.43

Target
$26.43

$20.55 $26.43 avg $40.48

Scenario Analysis

Bear Case

$20.55

500.0%

Low target

Base Case

$26.43

+671.7%

Avg target

Bull Case

$40.48

+1,081.9%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$23.25

-85.3% from high

52-Week Low

$2.80

+22.3% from low

Target vs 52W High

$26.43

+13.7% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+14.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.2%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+6.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+22.2%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+178.7%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+194.2%